Interestingly, the clinical trials in the patients having COVID-19 complications depicted faster recovery in patients post mesenchymal stem cells therapy owing to the decreased cytokines levels, anti-viral effects and regeneration of the infected tissue.
- Evaluates the role of MSCs to combat cytokine storm, the challenges regarding COVID-19 therapy, and how they can be countered with the use of stem cells and the risk of opportunistic infections post COVID-19
- Presents how stem cell therapy has emerged as a potential treatment for viral diseases, including but not limited to COVID-19
- Provides a detailed understanding of the novel coronavirus, with an emphasis on the therapeutic aspects
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.